A detailed history of Core Cap Advisors, LLC transactions in Cortexyme, Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 431 shares of CRTX stock, worth $555. This represents 0.0% of its overall portfolio holdings.

Number of Shares
431
Previous 431 -0.0%
Holding current value
$555
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
N/A
431 New
431 $0
Q4 2022

Feb 10, 2023

BUY
N/A
431 New
431 $0
Q2 2022

Aug 11, 2022

BUY
$2.22 - $6.7 $956 - $2,887
431 New
431 $1,000
Q1 2022

Apr 29, 2022

SELL
$4.18 - $13.39 $1,801 - $5,771
-431 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$11.35 - $97.17 $4,891 - $41,880
431 New
431 $5,000

Others Institutions Holding CRTX

About Cortexyme, Inc.


  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.